Micropharma (intellectual property assets)
M&A
STATUS
Buyout/LBO
LATEST DEAL TYPE
1
FINANCING ROUNDS
Description
Portfolio of intellectual property assets in the probiotic sector. The assets are related to development of the probiotic strain Lactobacillus reuteri NCIMB 30242, which is offered under the mark LRC and the Cardioviva brand of probiotics. It is protected by two families of registered patents.
Primary Office
- Montreal
- Canada
Micropharma (intellectual property assets) Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore Micropharma (intellectual property assets)‘s full profile, request access.
Request full access to PitchBookMicropharma (intellectual property assets) Former Investors
| Investor Name | Investor Type | Holding | Participating Rounds | Investor Since | Board Seat | Contact Info |
|---|
This information is reserved for PitchBook Platform users. To explore Micropharma (intellectual property assets)‘s full profile, request access.
Request full access to PitchBook